Bacil Pharma Ltd Share Price

Q: What is the share price of Bacil Pharma Ltd today?

Bacil Pharma Ltd share price as on 24 Jan 2025 is ₹43.36

Pharmaceuticals - Indian - Bulk Drugs

BSE: 524516 Small Cap ISIN: INE711D01018

As on 24 January 2025 at 05:41 IST

₹43.36

+ 0.18

(0.42%)

Sell Buy

Over 1 Month

-27.84%

Over 6 Months

147.21%

Over 1 Year

480.46%

Over 3 Years

380.18%

Bacil Pharma Ltd Summary

Close ₹ 43.36

Open ₹ 43.18

High ₹ 45.33

Low ₹ 41.50

Volume 9,018

Net Turnover (in ₹) ₹ 3,81,926

52Wk High ₹ 62.56

52Wk Low ₹ 7.03

52Wk High / Low

7.03

62.56

Bacil Pharma Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 25.54

EPS (TTM) 0.59

Book Value (BV) 1.79

Div. Yield -

P/E (TTM) 73.49

Price/Book Value 24.27

Delivery % 100 %

Face Value 10

Key Ratios

PE Ratio -

PB Ratio 7.87

EV to Sales -

PEG Ratio -

ROA -4.58

ROE -

Debt-Equity 0.05

Net Profit Margin -

Operating Profit Margin -

Bacil Pharma Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

No data available

Balance Sheet

No data available

Cash Flow

No data available

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	0.13	0.11	0.06	0.07	0.14
Total Expenses	0.19	0.22	3.92	0.31	0.46
Profit Before Tax	-0.06	-0.10	-3.86	-0.24	-0.32
Profit After Tax	-0.06	-0.10	-3.86	-0.24	-0.32
Operating Profit after Depreciation	-0.06	-0.10	-3.86	-0.24	-0.32

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	0.01	0.01	0.01	2.51	2.52
Total Non Current Assets	1.27	0.90	0.96	3.79	3.82
Total Current Assets	0.05	0.23	0.32	0.30	0.29
TOTAL ASSETS	1.33	1.13	1.27	4.09	4.11
Total Shareholder's Fund	1.21	1.10	1.22	1.39	1.39

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	-	-0.15	-4.01	-0.40	-0.38
Net Cash used in Investing Activities	0.08	-0.12	3.81	0.53	0.39
Net Cash used in Financing Activities	-0.06	0.06	0.33	-0.07	-0.06

No data available

Particulars (in ₹ Cr.)	2024-12	2024-09	2024-06	2024-03	2023-12
Total Revenue	-	-	-	-	-
Total Expenses	0.06	0.07	0.04	0.06	0.06
Profit Before Tax	-0.06	0.49	-0.03	-0.04	-0.03
Profit After Tax	-0.06	0.48	-0.03	-0.04	-0.02
Operating Profit after Depreciation	-0.06	0.49	-0.03	-0.04	-0.03

Bacil Pharma Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 40.87

S2 38.57

S3 36.63

Pivot 42.81

R1 45.11

R2 47.05

R3 49.35

Moving Average

20 SMA 47.69

50 SMA 50.84

100 SMA 41.50

200 SMA 31.04

Bacil Pharma Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

No available data

AGM Date: 29 Sep 2022

AGM 29/09/2022 Outcome Of Board Meeting For Approval Of Notice Of Annual General Meeting And Board Of Directors Report, Fixation Of Book Closure For AGM And Remote Evoting Facility, Appointment Of Scrutinizer Along with Routine Business. Annual General Meeting To Be Held On 29th September 2022. Pursuant to Section 91 of the Companies Act, 2013 and regulation 42 of SEBI(LODR) Regulation, 2015 the Register of Members and Share transfer books of the Company will remain closed from 23rd September, 2022 to 29th September, 2022 (Both day inclusive). (As per BSE Announcement Dated on 1/9/2022) Submission of Annual Report under Regulation 34(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. SUBMISSION OF NEWSPAPER CLIPPING FOR NOTICE OF AGM TO BE HELD ON 29TH SEPTEMBER,2022. (As per BSE Announcement Dated on 7/9/2022) Proceedings of 35th Annual General Meeting of Bacil Pharma Limited held on 29th September, 2022. Appointment of M/s. Laxmikant Kabra & Co. LLP, Chartered Accountants, as Statutory Auditor of the company for a term of five year from the conclusion of 35th Annual general Meeting till the conclusion of 40th Annual General Meeting (AGM) to be held in the F.Y 2027. Appointment of Mrs. Suman Shah (DIN: 01764668) as Non Executive Non-Independent Director of the Company from the date of this 35th Annual General Meeting, liable to retire by rotation. Bacil Pharma Limited Consolidated Report of Scrutinizer for the 35th Annual General Meeting of the Company. (As Per BSE Announcement Dated on 29/09/2022) Submission of Voting Results for Bacil Pharma Limited. (As Per BSE Announcement Dated 01.10.2022)

AGM Date: 16 Sep 2023

Submission of newspaper clipping for the Annual Genral Meeting to be held on 16th September,2023 Submission of Proceedings of Annual General Meeting held on 16th September,2023 at 2.00 P.M Submission of Regulation 30 for appointment of Mr. Ganpat Salekar as Manager at the Annual General Meeting. (As per BSE Announcement Dated on 16/09/2023)

AGM Date: 27 Sep 2024

AGM 27/09/2024 Approval Of Notice Of Annual General Meeting And Board Of Directors Report, Fixation Of Book Closure For AGM And Remote Evoting Facility, Appointment Of Scrutinizer Along With Routine Business. (As Per BSE Announcement Dated on 02.09.2024) Proceedings of the 37th Annual General Meeting of the company Submission of Scrutinizer''s Report for 37th Annual General Meeting held on 27th September, 2024. (As Per BSE Announcement dated on 27.09.2024)

Bacil Pharma Ltd Peer Comparison

Company	Price	Market Cap (in ₹ Cr)
Bacil Pharma Ltd	₹43.36	₹25.54
Sun Pharmaceuticals Industries Ltd	₹1,834.05	₹4,40,050.03
Divis Laboratories Ltd	₹5,846.55	₹1,55,207.53
Cipla Ltd	₹1,451.15	₹1,17,196.91
Torrent Pharmaceuticals Ltd	₹3,266.20	₹1,10,538.08
Mankind Pharma Ltd	₹2,632.70	₹1,08,616.49

Bacil Pharma Ltd News

Bacil Pharma to discuss results

On 21 January 2025

14 Jan 2025, 02:13 pm

Bacil Pharma to convene EGM

On 14 November 2024

24 Oct 2024, 09:01 pm

Bacil Pharma to convene board meeting

On 23 October 2024

17 Oct 2024, 12:34 pm

Bacil Pharma schedules board meeting

On 15 October 2024

11 Oct 2024, 10:31 am

Bacil Pharma announces board meeting date

On 27 September 2024

23 Sep 2024, 10:09 am

Bacil Pharma Ltd Stock Analysis

Annual revenue for Bacil Pharma Ltd increased by 13.86% to ₹0.13 crore in FY 2024 from ₹0.11 crore in FY 2023.
Annual Net Profit for Bacil Pharma Ltd decreased by 42.04% to ₹-0.06 crore in FY 2024 from ₹-0.10 crore in FY 2023.
Promoter Shareholding in Bacil Pharma Ltd decreased by 51.48% in the most recent quarter, from 42.67% in June 2024 to 20.70% in September 2024.
Bacil Pharma Ltd delivered a 1-year return of 480.46% compared to the Nifty 50, which provided a return of 0% as of the last trading session.
Bacil Pharma Ltd share price moved up by 0.42% from its previous close of INR ₹43.18. The latest Bacil Pharma Ltd share price is INR ₹43.36.
Bacil Pharma Ltd share price today has been at a low of 41.50 and a high of 45.33. Over the past 52 weeks, the Bacil Pharma Ltd share price has seen a low of 7.03 and a high of 62.56.